Cell and Gene Therapy for Oncology Market
- 2026 年市場規模
- USD 8,641.9 Mn
- 2033 年預估規模
- USD 138,425.0 Mn
- 年複合成長率 CAGR
- 44.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cell and Gene Therapy for Oncology Market, By Therapy Type (Cell Therapy (Stem Cell Therapy, T-Cell Therapy, Mesenchymal Stem Cell (MSC) Therapy, and Others) and Gene Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Therapy Gene Transfer)), By Technology (Cell Therapy Technology (Autologous, Allogeneic, and Xenogeneic) and Gene Therapy Technology (Viral Vector-Based Gene Therapy and Non-Viral Vector-Based Gene Therapy)), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Leukaemia and Lymphoma, and Others), By End User (Hospitals and Cancer Treatment Centers, Research and Academic Institutes, Biotechnology and Pharmaceutical Companies, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
The global cell and gene therapy for oncology market is estimated to be valued at USD 8,641.9 Mn in 2026 and is expected to reach USD 138,425.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 44.7% from 2026 to 2033. The market for global cell and gene therapy for oncology is among the fastest-growing markets in the field of oncology therapeutics due to the growing number of cancers and the increasing need for personalized and targeted therapeutic solutions. The major firms engaged in this field are striving to develop state-of-the-art treatments such as CAR-T, TCR, and genetically engineered immunotherapy that provide better results than existing therapies.
The technological progress in gene editing, development of viral vectors, and cell engineering technologies is revolutionizing the cancer therapy process. There are several other factors contributing to the market's growth such as increased participation in clinical trials, approvals, and financial investments by biopharmaceutical companies. Moreover, rising use of precision medicine, improvements in production, and strategic partnerships are driving innovation in the cell and gene-based cancer treatment market.
Market Dynamics
The global cell and gene therapy for oncology market is spurred by an increasing burden of cancer across the globe and an increasing demand for oncology treatments that offer greater precision. Increased public awareness about new cancer therapies, coupled with advances made in techniques like CAR-T cell therapy, gene-editing, and viral vectors, is further boosting the growth of the market. Moreover, an increased number of clinical trials and investment in innovative oncology treatments by major players in biopharmaceuticals can be seen.
Some of the factors restricting the growth of the market include the high costs associated with oncology cell and gene therapy, the high costs of production, and stringent regulatory frameworks for the same. Safety issues related to the adverse side effects of such procedures, such as cytokine release syndrome, also present themselves. Nevertheless, there are ample opportunities for growth within the market, owing to the rise of allogenic and off-the-shelf therapies, wider applications for solid tumors, and increased investments in manufacturing facilities.
Key Features of the Study
• This report provides in-depth analysis of the global cell and gene therapy for oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell and gene therapy for oncology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Gilead Sciences, Novartis AG, Bristol Myers Squibb, Johnson & Johnson, Legend Biotech, bluebird bio, CRISPR Therapeutics, Allogene Therapeutics, Iovance Biotherapeutics, and Adaptimmune Therapeutics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cell and gene therapy for oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell and gene therapy for oncology market
Market Segmentation
• Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
o Cell Therapy
Stem Cell Therapy
T-Cell Therapy
Mesenchymal Stem Cell (MSC) Therapy
Others
o Gene Therapy
Gene Induced Immunotherapy
Oncolytic Virotherapy
Therapy Gene Transfer
• Technology Insights (Revenue, USD Mn, 2021 - 2033)
o Cell Therapy Technology
Autologous
Allogeneic
Xenogeneic
o Gene Therapy Technology
Viral Vector-Based Gene Therapy
Non-Viral Vector-Based Gene Therapy
• Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Breast Cancer
o Lung Cancer
o Prostate Cancer
o Leukaemia and Lymphoma
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals and Cancer Treatment Centers
o Research and Academic Institutes
o Biotechnology and Pharmaceutical Companies
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Gilead Sciences
o Novartis AG
o Bristol Myers Squibb
o Johnson & Johnson
o Legend Biotech
o bluebird bio
o CRISPR Therapeutics
o Allogene Therapeutics
o Iovance Biotherapeutics
o Adaptimmune Therapeutics
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Cell and Gene Therapy for Oncology Market, By Therapy Type
Global Cell and Gene Therapy for Oncology Market, By Technology
Global Cell and Gene Therapy for Oncology Market, By Indication
Global Cell and Gene Therapy for Oncology Market, By End User
Global Cell and Gene Therapy for Oncology Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Cell and Gene Therapy for Oncology Market, By Therapy Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Stem Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o T-Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Mesenchymal Stem Cell (MSC) Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gene Induced Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Oncolytic Virotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Therapy Gene Transfer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Cell and Gene Therapy for Oncology Market, By Technology, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Cell Therapy Technology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Autologous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Allogeneic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Xenogeneic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Gene Therapy Technology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Viral Vector-Based Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Non-Viral Vector-Based Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Cell and Gene Therapy for Oncology Market, By Indication, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Leukaemia and Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Cell and Gene Therapy for Oncology Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals and Cancer Treatment Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Research and Academic Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Biotechnology and Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Cell and Gene Therapy for Oncology Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Gilead Sciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bristol Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Legend Biotech
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o bluebird bio
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o CRISPR Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Allogene Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Iovance Biotherapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Adaptimmune Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Cell and Gene Therapy for Oncology Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們